Category: SPMS-PPMS News

Secondary progressive multiple sclerosis therapeutic pipeline market review for 2014 just published

The report “Secondary Progressive Multiple Sclerosis (SPMS) Pipeline Review, H2 2014” provides an overview of the Secondary Progressive Multiple Sclerosis…

Stuart Schlossman

The Progressive MS Alliance invites you to join an informational call to learn more about a new funding initiative just released by the Alliance.

Progressive MS Alliance The Progressive MS Alliance invites you to join an informational call to learn more about a new…

Stuart Schlossman

Primary Progressive Multiple Sclerosis Market

Transparency Market Research includes new market research report “Primary Progressive Multiple Sclerosis Market” to its huge collection of research reports.…

Stuart Schlossman

Some Astrocytes Appear to Promote Progressive MS

October 2014 Researchers have identified a key enzyme in astrocytes that turns on during the progressive stage of multiple sclerosis,…

Stuart Schlossman

Opexa Therapeutics to Present at Cleveland Clinic’s 12th Annual Medical Innovation Summit

October 20, 2014 THE WOODLANDS, Texas–(BUSINESS WIRE)– Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune…

Stuart Schlossman

Secondary Progressive Multiple Sclerosis (SPMS) in Australia

The MIS416 trial is a clinical research trial now enrolling patients with Secondary Progressive Multiple Sclerosis (SPMS) in Australia. Full…

Stuart Schlossman

Primary, Secondary Progressive MS Therapy to be Tested in Phase 2 Trial by MediciNova

MediciNova, Inc., recently announced that it had surpassed 50% enrollment for the phase 2b clinical trial evaluating MN-166 (ibudilast) in…

Stuart Schlossman

The Science of MS Management: Update on Progressive Forms of Multiple Sclerosis

The Science of MS Management: Update on Progressive Forms of Multiple SclerosisCorey C. Ford, MD, PhD; Emmannuelle Waubant, MD, PhD…

Stuart Schlossman

New study will explore potential treatment (ibudilast )for progressive MS

 PDF  At this time, there is a significant gap in available treatment options for people living with progressive MS. The…

Stuart Schlossman

Different Goals, But a Continued Role, For Neurologists In Late Secondary Progressive MS

 R. Philip Kinkel, MD Neurologists can and should continue to play an important role in the care of patients with…

Stuart Schlossman

Categories

Latest Blog Posts